» Articles » PMID: 20015984

Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid During Primary Infection

Overview
Journal J Virol
Date 2009 Dec 18
PMID 20015984
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is a severe neurological disease that affects a subset of HIV-1-infected individuals. Increased compartmentalization has been reported between blood and cerebrospinal fluid (CSF) HIV-1 populations in subjects with HAD, but it is still not known when compartmentalization arises during the course of infection. To assess HIV-1 genetic compartmentalization early during infection, we compared HIV-1 populations in the peripheral blood and CSF in 11 primary infection subjects, with analysis of longitudinal samples over the first 18 months for a subset of subjects. We used heteroduplex tracking assays targeting the variable regions of env and single-genome amplification and sequence analysis of the full-length env gene to identify CSF-compartmentalized variants and to examine viral genotypes within the compartmentalized populations. For most subjects, HIV-1 populations were equilibrated between the blood and CSF compartments. However, compartmentalized HIV-1 populations were detected in the CSF of three primary infection subjects, and longitudinal analysis of one subject revealed that compartmentalization during primary HIV-1 infection was resolved. Clonal amplification of specific HIV-1 variants was identified in the CSF population of one primary infection subject. Our data show that compartmentalization can occur in the central nervous system (CNS) of subjects in primary HIV-1 infection in part through persistence of the putative transmitted parental variant or via viral genetic adaptation to the CNS environment. The presence of distinct HIV-1 populations in the CSF indicates that independent HIV-1 replication can occur in the CNS, even early after HIV-1 transmission.

Citing Articles

Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection.

Chan P, Li X, Li F, Emu B, Price R, Spudich S Front Immunol. 2025; 16:1531828.

PMID: 40070827 PMC: 11893981. DOI: 10.3389/fimmu.2025.1531828.


HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives.

Kelly S, Nightingale S, Gupta R, Collier D Trop Med Infect Dis. 2025; 10(2).

PMID: 39998049 PMC: 11860496. DOI: 10.3390/tropicalmed10020045.


Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation.

Kincer L, Dravid A, Trunfio M, Calcagno A, Zhou S, Vercesi R J Clin Invest. 2024; 134(19).

PMID: 39352388 PMC: 11444166. DOI: 10.1172/JCI176358.


Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.

Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H PLoS Pathog. 2024; 20(9):e1012470.

PMID: 39316609 PMC: 11469498. DOI: 10.1371/journal.ppat.1012470.


Evolution of SARS-CoV-2 in the murine central nervous system drives viral diversification.

Class J, Simons L, Lorenzo-Redondo R, Achi J, Cooper L, Dangi T Nat Microbiol. 2024; 9(9):2383-2394.

PMID: 39179693 DOI: 10.1038/s41564-024-01786-8.


References
1.
Ritola K, Pilcher C, Fiscus S, Hoffman N, Nelson J, Kitrinos K . Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol. 2004; 78(20):11208-18. PMC: 521858. DOI: 10.1128/JVI.78.20.11208-11218.2004. View

2.
Lindback S, Karlsson A, Mittler J, Blaxhult A, Carlsson M, Briheim G . Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS. 2000; 14(15):2283-91. DOI: 10.1097/00002030-200010200-00009. View

3.
Delwart E, Mullins J, Gupta P, Learn Jr G, Holodniy M, Katzenstein D . Human immunodeficiency virus type 1 populations in blood and semen. J Virol. 1998; 72(1):617-23. PMC: 109415. DOI: 10.1128/JVI.72.1.617-623.1998. View

4.
Strain M, Letendre S, Pillai S, Russell T, Ignacio C, Gunthard H . Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol. 2005; 79(3):1772-88. PMC: 544082. DOI: 10.1128/JVI.79.3.1772-1788.2005. View

5.
Ritola K, Robertson K, Fiscus S, Hall C, Swanstrom R . Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol. 2005; 79(16):10830-4. PMC: 1182623. DOI: 10.1128/JVI.79.16.10830-10834.2005. View